Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 21, 2019
Pharmacy Choice - Pharmaceutical News - Breast Cancer Market is Expected to Witness a Significant Growth by 2025 | Hexa Research - January 21, 2019

Pharmacy News Article

 1/11/19 - Breast Cancer Market is Expected to Witness a Significant Growth by 2025 | Hexa Research

Research Report on Breast Cancer Market Size, Shares, Growth, Application Analysis, Competitive Market Strategies and Forecasts, 2015 to 2025

The global Breast Cancer Market is anticipated to witness a significant growth over the forecast period on account of growing target population base across the globe, rising prevalence of the disease, unhealthy lifestyle, exposure to radiations, and lack of physical exercises. Moreover, increasing efforts taken by major organizations across various regions to increase awareness levels is estimated to drive the market. Rising investments in R&D by various government and private organizations for development of effective drugs and treatments is also projected to play a key role in the market growth.

For instance, CytoDyn Inc., a biotech firm developing humanized CCR5 monoclonal antibodies for several therapeutic indications, received FDA approval for its Investigation New Drug (IND) submission and is allowed to start a phase 1b/2 trial for metastatic Triple-Negative Breast Cancer (TNBC). This disease subtype is one of the leading causes of cancer deaths across the globe and it accounts for around 10 % of the overall cases. The firm has identified several trial sites and aims to dose a few patients and expects to have initial readout during the first quarter of 2019. Changes in the number of Circulating Tumor Cells (CTCs) will be assessed every 21 days throughout the trial.

Breast cancer is detected during a screening test or after the patient notices a lump, which is the most common physical sign. According to the World Health organization (WHO), every year, about 200,000 new cases of breast cancer are diagnosed globally and this number is likely to increase in future. Some of the major types of breast cancer are ductal carcinoma in situ (DCIS), Invasive Ductal Carcinoma (IDC), and lobular carcinoma. Invasive ductal carcinoma hold a major share in the market owing to growing prevalence of IDC, government support, and initiatives undertaken to increase awareness among patients. Furthermore, unmet clinical needs in treatment of IDC has compelled manufacturers to conduct rigorous R&D activities. Chemotherapy, targeted, surgery and radiation, hormone, and biologic therapies are some of the most popular treatments for the disease.

Browse Details of Report @

https://www.hexaresearch.com/research-report/breast-cancer-market

North America has emerged as the prominent region in the market on account of changing lifestyle, growing prevalence of the disease, and presence of leading companies in U.S. Europe is likely to emerge highly lucrative over the coming years as a result of increased healthcare expenditure and technological developments. Countries, including Germany, France, and U.K., are some of the key revenue-generating economies in Europe.

Asia pacific is also projected to witness a considerable growth over the next few years owing to rapidly developing healthcare infrastructure and rising consumer disposable income. Moreover, ongoing awareness programs about breast cancer and available treatments by governments in the emerging countries, such as China and India are estimated to foster the growth.

Companies are adopting several business strategies, such as novel product development, technological advancements, and M&A in order to strengthen their foothold in the industry. For example, FDA recently approved the Investigational New Drug (IND) application for Athenex's oral form of Eribulin. It is an anticancer drug promoted by Eisai Company under the brand name Halaven and can effectively treat metastatic breast cancer and liposarcoma. The company is allowed to initiate clinical trial program, which is expected to start in the first half of 2019. Other targeted therapies introduced to treat breast cancer include Perjeta (pertuzumab) and Kadcyla (T-DM1), which is a human antibody-drug conjugate. Leading companies operating in the global breast cancer market include Pfizer, Inc.; Novartis AG; Apthera, Inc.; BioNumerik Pharmaceuticals, Inc.; Eli Lilly and Company; and Oncothyreon, Inc.

Browse Related Category Reports @

Protein Therapeutics Market : - Some of the key trends in the Protein Therapeutics Market are hepatic metabolism and rapid elimination and increasing focus on development of Biobetters.

Animal Health Market : - Advancing veterinary care technologies coupled with high prevalence of zoonotic diseases is expected to drive Animal Health Market growth.

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

More Information Visit @ www.hexaresearch.com

Media Contact

Company Name: Hexa Research

Contact Person: Ryan Shaw

Email: sales@hexaresearch.com

Phone: +1-800-489-3075

Address:Felton Office Plaza, 6265 Highway 9

City: Felton

State: California 95018

Country: United States

Website: www.hexaresearch.com/research-report/breast-cancer-market

Source: www.abnewswire.com

.



(C) 2019 M2 COMMUNICATIONS

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Jan 22: Medication Use During Pregnancy & Lactation
Last Chance
Jan 23: ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Jan 24: COPD Update for Pharmacy Professionals
Jan 28: From Memory to Alzheimer’s - Supporting Memory With Lifestyle Medicine
Jan 29: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415